Literature DB >> 11232238

Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action.

J Gil1, M Esteban.   

Abstract

Interferons are a family of cytokines that exerts antiviral, antitumor and immunomodulatory actions by inducing a complex set of proteins. One of the best known IFN-induced protein is the dsRNA-dependent protein kinase (PKR), that mediates both antiviral and anticellular activities. PKR inhibits translation initiation through the phosphorylation of the alpha subunit of the initiation factor eIF-2 (eIF-2 alpha) and also controls the activation of several transcription factors such as NF-kappa B, p53, or STATs. In addition, PKR mediates apoptosis induced by many different stimuli, such as treatment with LPS, TNF-alpha, viral infection, or serum starvation. The mechanism of apoptosis induction by PKR involves phosphorylation of eIF-2 alpha and activation of NF-kappa B. In this way, expression of different genes is regulated by PKR. Among the genes upregulated in response to PKR are Fas, Bax and p53. The pathway of PKR-induced apoptosis involves FADD activation of caspase 8 by a mechanism independent of Fas and TNFR. Since IFNs are used as drugs for different disorders such as viral infection and cancer, understanding the pathway of apoptosis induction triggered by PKR should be useful in the rational design of IFN therapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11232238     DOI: 10.1023/a:1009664109241

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  103 in total

1.  Stable suppression of gene expression by RNAi in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

3.  Inducible shRNA expression for application in a prostate cancer mouse model.

Authors:  Frank Czauderna; Ansgar Santel; Michael Hinz; Melanie Fechtner; Birgit Durieux; Gerald Fisch; Frauke Leenders; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

4.  High-throughput selection of effective RNAi probes for gene silencing.

Authors:  Rajeev Kumar; Douglas S Conklin; Vivek Mittal
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

Review 5.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

7.  Can RNA interference be used to expand the plasticity of autologous adult stem cells?

Authors:  Boon Chin Heng; Tong Cao
Journal:  J Mol Med (Berl)       Date:  2004-09-14       Impact factor: 4.599

Review 8.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

9.  Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weakness.

Authors:  G S Supinski; L A Callahan
Journal:  J Appl Physiol (1985)       Date:  2010-11-11

10.  An approach to genomewide screens of expressed small interfering RNAs in mammalian cells.

Authors:  Lianxing Zheng; Jun Liu; Sergei Batalov; Demin Zhou; Anthony Orth; Sheng Ding; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.